{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:52:19Z","timestamp":1791348739834,"version":"4.3.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/mol.0b013e3283471972","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T07:52:27Z","timestamp":1303804347000},"page":"247-253","source":"Crossref","is-referenced-by-count":116,"title":["Genetic bases of hypertriglyceridemic phenotypes"],"prefix":"10.1097","volume":"22","author":[{"given":"Christopher T.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20211004","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/138945009787846452","article-title":"Primary and secondary hypertriglyceridaemia.","volume":"10","author":"Kolovou","year":"2009","journal-title":"Curr Drug Targets"},{"key":"R2-2-20211004","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment.","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"R3-2-20211004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides.","volume":"52","author":"Johansen","year":"2011","journal-title":"J Lipid Res"},{"key":"R4-2-20211004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOL.0b013e3283319a1d","article-title":"Severe hypertriglyceridemia and pancreatitis: presentation and management.","volume":"20","author":"Ewald","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"R5-2-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R6-2-20211004","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0021-9150(98)00219-6","article-title":"Triglycerides are more important in atherosclerosis than epidemiology has suggested.","volume":"141","author":"Durrington","year":"1998","journal-title":"Atherosclerosis"},{"key":"R7-2-20211004","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.atherosclerosis.2010.03.006","article-title":"All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: a long-term prospective registry study.","volume":"211","author":"Neil","year":"2010","journal-title":"Atherosclerosis"},{"key":"R8-2-20211004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"R9-2-20211004","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jcem.85.6.6642-1","article-title":"Hyperlipidemia: diagnostic and therapeutic perspectives.","volume":"85","author":"Ballantyne","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-2-20211004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-75-3-471","article-title":"An international classification of hyperlipidemias and hyperlipoproteinemias.","volume":"75","author":"Fredrickson","year":"1971","journal-title":"Ann Intern Med"},{"key":"R11-2-20211004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications.","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"R12-2-20211004","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2796.1992.tb01256.x","article-title":"Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II.","volume":"231","author":"Fojo","year":"1992","journal-title":"J Intern Med"},{"key":"R13-2-20211004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1139\/Y09-005","article-title":"Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review.","volume":"87","author":"Rahalkar","year":"2009","journal-title":"Can J Physiol Pharmacol"},{"key":"R14-2-20211004","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI113246","article-title":"Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease.","volume":"80","author":"Connelly","year":"1987","journal-title":"J Clin Invest"},{"key":"R15-2-20211004","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1073\/pnas.84.1.270","article-title":"Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein.","volume":"84","author":"Connelly","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-2-20211004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"R17-2-20211004","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.","volume":"115","author":"Marcais","year":"2005","journal-title":"J Clin Invest"},{"key":"R18-2-20211004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1373\/clinchem.2004.044826","article-title":"Apolipoprotein A5 and hypertriglyceridemia.","volume":"51","author":"Charlton-Menys","year":"2005","journal-title":"Clin Chem"},{"key":"R19-2-20211004","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia.","volume":"39","author":"Peterfy","year":"2007","journal-title":"Nat Genet"},{"key":"R20-2-20211004","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/jc.2009-0594","article-title":"Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.","volume":"94","author":"Cefalu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-2-20211004","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOL.0b013e32833854c0","article-title":"Lipase maturation factor 1: structure and role in lipase folding and assembly.","volume":"21","author":"Doolittle","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"R22-2-20211004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-511X-6-23","article-title":"Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650).","volume":"6","author":"Wang","year":"2007","journal-title":"Lipids Health Dis"},{"key":"R23-2-20211004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/ATVBAHA.109.186577","article-title":"Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.","volume":"29","author":"Beigneux","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-2-20211004","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1194\/jlr.M002717","article-title":"Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.","volume":"51","author":"Olivecrona","year":"2010","journal-title":"J Lipid Res"},{"key":"R26-2-20211004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metab"},{"key":"R27-2-20211004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MOL.0b013e32832ac026","article-title":"GPIHBP1 and lipolysis: an update.","volume":"20","author":"Beigneux","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"R28-2-20211004","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/jc.2007-0275","article-title":"Update on dyslipidemia.","volume":"92","author":"Garg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-2-20211004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","article-title":"Inherited lipodystrophies and hypertriglyceridemia.","volume":"20","author":"Simha","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"R30-2-20211004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosissup.2010.03.004","article-title":"Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.","volume":"11","author":"Gaudet","year":"2010","journal-title":"Atheroscler Suppl"},{"key":"R31-2-20211004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOL.0b013e328336eae9","article-title":"Strategies for identifying the genetic basis of dyslipidemia: genome-wide association studies vs. the resequencing of extremes.","volume":"21","author":"Khor","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"R32-2-20211004","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ng.628","article-title":"Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.","volume":"42","author":"Johansen","year":"2010","journal-title":"Nat Genet"},{"key":"R33-2-20211004","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids.","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"R34-2-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20080595","article-title":"Glucokinase and molecular aspects of liver glycogen metabolism.","volume":"414","author":"Agius","year":"2008","journal-title":"Biochem J"},{"key":"R35-2-20211004","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2337\/db08-0516","article-title":"Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.","volume":"57","author":"Orho-Melander","year":"2008","journal-title":"Diabetes"},{"key":"R36-2-20211004","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.","volume":"18","author":"Beer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R38-2-20211004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCGENETICS.109.934505","article-title":"Extremes of unexplained variation as a phenotype: an efficient approach for genome-wide association studies of cardiovascular disease.","volume":"3","author":"Lanktree","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R39-2-20211004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases.","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"R40-2-20211004","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","article-title":"Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.","volume":"111","author":"Rader","year":"2003","journal-title":"J Clin Invest"},{"key":"R41-2-20211004","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ncpcardio1326","article-title":"APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.","volume":"5","author":"Wang","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"R42-2-20211004","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.P800011-JLR200","article-title":"An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.","volume":"49","author":"Pullinger","year":"2008","journal-title":"J Lipid Res"},{"key":"R43-2-20211004","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/hmg\/ddp361","article-title":"A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.","volume":"18","author":"Hegele","year":"2009","journal-title":"Hum Mol Genet"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201108000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:48:59Z","timestamp":1633312139000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201108000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e3283471972","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}